3 
International  Conference. 
(Am.  Jour.  Pharm. 
I     January.  1903. 
Belgium — Alf.  Devaux,  J.  B.  Depaire,  G.  Bruylants,  A.  Jorissen, 
F.  J.  Heymans,  Fernand  Ranwez,  L.  Van  Hulst. 
Bulgaria — Al.  I.  Naidenovitch. 
Denmark — H.  J.  Moller. 
France — C.  M.  Gariel,  Em.  Bourquelot,  P.  Yvon. 
Great  Britain — Donald  MacAlister. 
British  India — Jas.  Reid. 
Italy — Emmanuel  Paterno  di  Sessa. 
Luxemburg — Dr.  Fonck,  H.  Gusenburger. 
The  Netherlands — B.  J.  Stokvis,  L.  van  Itallie,  M.  GreshofL 
Norway — E.  Poulsson. 
Russia — W.  A.  Tikhomirow. 
Sweden — Severin  Jolin. 
Switzerland — A.  Tschirch,  C.  Buhrer. 
United  States  of  America — Frederick  B.  Power.1 
It  was  somewhat  to  be  regretted  that  the  delegates  representing 
the  United  States  and  Great  Britain  should  have  received  from  their 
respective  governments  the  official  intimation  of  their  appointment 
but  a  few  weeks  before  the  opening  of  the  Conference,  as  sufficient 
time  was  thus  not  available  to  enable  them  to  formulate  and  present, 
in  advance  of  the  meeting,  a  more  comprehensive  expression  of  their 
views  respecting  the  various  subjects  to  be  brought  forward  for  dis- 
cussion. 
One  of  the  subjects  in  this  connection  which  had  suggested  itself 
to  the  writer  as  worthy  of  careful  consideration  was  the  desirability 
of  adopting  the  well-defined  active  principles  of  certain  drugs — 
alkaloids,  glucosides,  etc.,  in  the  place  of  their  so-called  galenical 
preparations.  Such  a  proposal  should  naturally  be  consistent  with 
existing  knowledge  respecting  the  physiological  action  of  the  drugs 
and  that  of  the  active  principles  that  have  thus  far  been  isolated 
from  them,  and  would  thus  have  some  well-recognized  and  positive 
limitations.  The  fact  was  therefore  not  overlooked  that  some 
valuable  medicinal  drugs  are  not  represented,  and  cannot  be  replaced, 
by  a  single  active  constituent,  even  though  the  latter  may  be  most 
useful  in  itself.    This  is  notably  the  case  with  opium,  which  will 
*Dr.  K.  C.  Wood,  who  also  represented  the  United  States  as  a  delegate,  and 
took  an  active  part  in  the  deliberations  of  the  Conference,  was  unable  to  be 
present  at  the  closing  session  on  account  of  arrangements  for  his  homeward 
journey. 
